In a first, brain implant lets man with complete paralysis spell out thoughts: ‘I love my cool son.’
By Kelly Servick,
Science
| 03. 22. 2022
In its final stages, the neurological disease amyotrophic lateral sclerosis (ALS) can bring extreme isolation. People lose control of their muscles, and communication may become impossible. But with the help of an implanted device that reads his brain signals, a man in this “complete” locked-in state could select letters and form sentences, researchers report this week.
“People have really doubted whether this was even feasible,” says Mariska Vansteensel, a brain-computer interface researcher at the University Medical Center Utrecht who was not involved in the study, published in Nature Communications. If the new spelling system proves reliable for all people who are completely locked in—and if it can be made more efficient and affordable—it might allow thousands of people to reconnect to their families and care teams, says Reinhold Scherer, a neural engineer at the University of Essex.
ALS destroys the nerves that control movement, and most patients die within 5 years of diagnosis. When a person with ALS can no longer speak, they can use an eye-tracking camera to select letters on a screen. Later in the disease’s...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...